Trial Profile
Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Oct 2022
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Tacrolimus (Primary) ; Mycophenolic acid
- Indications Liver transplant rejection
- Focus Biomarker; Pharmacodynamics
- 06 Apr 2021 Status changed from recruiting to completed.
- 12 Apr 2019 Planned End Date changed from 1 Mar 2019 to 1 Mar 2021.
- 12 Apr 2019 Planned primary completion date changed from 1 Mar 2018 to 1 Mar 2020.